Dual CD33/CLL1 CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dual CD33/CLL1 CAR T cells, covering 2025-06-11 to 2025-06-11. Get the full timeline:
Most recent: Clinical Trial Update: Optimized Dual CD33/CLL1 CAR T Cells in Subjects With Refractory or Relapsed Acute Myeloid Leukemia [Phase 1]